MLE

VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform

Retrieved on: 
Tuesday, April 2, 2024
Research, Infectious Diseases, FDA, Clinical Trials, Other Health, Biotechnology, Pharmaceutical, Health, Science, Oncology, Strategic Innovation Fund, Disease, Partnership, Vaccine, RNA, Messenger, MLE, National Research Council, Government, CAD, VBI

In preclinical studies, VBI’s MLE candidates generated strong B-cell and T-cell signals compared to those seen with other mRNA vaccines tested.

Key Points: 
  • In preclinical studies, VBI’s MLE candidates generated strong B-cell and T-cell signals compared to those seen with other mRNA vaccines tested.
  • The technology platform also offers potential for streamlined manufacturing timelines, similar to other mRNA vaccines.
  • “We are grateful for the continued support of our long-term partners in the Canadian government, and are pleased to extend our work together to investigate our novel MLE platform, which we think has the potential to revolutionize particulate vaccines,” said Jeff Baxter, President and CEO of VBI.
  • Consistent with the strategic intent of the original agreement, development will primarily focus on platform development and will also include a pan-coronavirus MLE candidate to contribute toward future epidemic and pandemic preparedness.

NFL Star Joey Bosa Takes on World Champion Competitive Eater Joey Chestnut at the Second Annual Wonderful® Pistachios Get Crackin' Eating Championship

Retrieved on: 
Thursday, February 1, 2024
NFL, Athlete, Pistachio, MLE, Major League Eating, History, Los Angeles Chargers

Hosted by Wonderful® Pistachios and Major League Eating (MLE), this marks the first time in the competitive eating-circuit history that an active professional football player will go head-to-head with internationally-ranked MLE athletes, including the defending Pistachios Eating World Champion Nick Wehry.

Key Points: 
  • Hosted by Wonderful® Pistachios and Major League Eating (MLE), this marks the first time in the competitive eating-circuit history that an active professional football player will go head-to-head with internationally-ranked MLE athletes, including the defending Pistachios Eating World Champion Nick Wehry.
  • Bosa’s impressive athletic accolades, including his history as a four-time player in the NFL Pro Bowl, make him a formidable opponent.
  • In addition to Bosa, top-ranked eaters from around the world will attend including:
    #1-ranked Joey Chestnut from Westfield, Ind.
  • #4-ranked and current Pistachios Eating World Champion, Nick Wehry from Tampa, Fla.

VBI Vaccines Reports Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 14, 2023
Biotechnology, FDA, Other Health, Health, Pharmaceutical, Oncology, Research, Infectious Diseases, Science, COVID-19, Clinical Trials, Shekel, MLE, High-net-worth individual, Hepatitis B vaccine, GMT, HBsAg, Net, AASLD, Bank statement, Disease, GBM, Government, Administration, Patient, HBV, Research and development, Prison, Allergy, Fast track (FDA), Autoimmune disease, InSight, Liver, VBI, Messenger, Internationalized domain name, GAAP, Vaccine, Cancer, Partnership, R, Seroconversion, Growth, Infection, Israeli new shekel, Pharmaceutical industry, Video game, Rare-earth element, Cryptocurrency, Bank

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended September 30, 2023.

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended September 30, 2023.
  • Cost of Revenues: Cost of revenues was $2.5 million in the third quarter of 2023 as compared to $2.7 million in the third quarter of 2022.
  • Research and Development (R&D): R&D expenses for the third quarter of 2023 were $1.5 million as compared to $5.0 million for the third quarter of 2022.
  • Non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with, GAAP financial results.

Methylennium Energy Receives Investment From The Process Group LLC

Retrieved on: 
Tuesday, November 14, 2023
Professional Services, Sustainability, Alternative Energy, Alternative Vehicles, Fuels, Start-Up, Energy, Automotive, Environment, Engineering, Maritime, Air, Transport, Manufacturing, Aviation, TPG, Process group, CO2, MLE, SAF, Multimedia, Hydrogen, Process, Renewable energy

Methylennium Energy (MLE) today announces receiving an initial investment of cash and in-kind engineering design services from The Process Group LLC.

Key Points: 
  • Methylennium Energy (MLE) today announces receiving an initial investment of cash and in-kind engineering design services from The Process Group LLC.
  • MLE is offering a platform for production of cost-competitive carbon-neutral e-methanol from waste CO2 and renewable hydrogen.
  • The advantages of the Methylennium process are:
    This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20231114826501/en/
    Flexible methanol synthesis reactor and process enables the use of intermittent power sources.

Taylor's Continues to Ascend Among Asia's Best, ranks 41 in the latest Asia University Rankings

Retrieved on: 
Wednesday, November 8, 2023
Curriculum framework, Faculty, Education, QS World University Rankings, Taylor's University, Growth, Curriculum, University, Student, MLE, International Research Universities Network, Climate change, Nursing, Management

SUBANG JAYA, Malaysia, Nov. 8, 2023 /PRNewswire/ -- Taylor's University has once again soared to new heights, securing a distinguished #41 position in the latest QS Asia University Rankings 2024.

Key Points: 
  • SUBANG JAYA, Malaysia, Nov. 8, 2023 /PRNewswire/ -- Taylor's University has once again soared to new heights, securing a distinguished #41 position in the latest QS Asia University Rankings 2024.
  • This exceptional progress is marked by significant growth in 5 key indicators, including International Research Number, Citations per Paper, Faculty-Student Ratio, International Faculty and Academic Reputation.
  • Taylor's University is known for its transformative Multidisciplinary Learning Experience (MLE) that blends various subjects to create innovative programmes.
  • Recent global events highlight the importance of addressing contemporary challenges, such as technological advancement, globalisation, demographic shifts, and climate change.

VBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine Program

Retrieved on: 
Thursday, October 26, 2023
Research, Infectious Diseases, FDA, Clinical Trials, Other Health, Biotechnology, Pharmaceutical, Health, Science, Oncology, Mouse, Infection, RNA, Antigen, CD4, CMC, Vaccine, CD8, VBI, Disease, Messenger, Autoimmune disease, MLE, Human body, Allergy, Cancer, Chemistry, Immunization

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the development of its next-generation mRNA-launched enveloped virus-like particle (eVLP) technology, which expands on the company’s current proprietary eVLP technology by coding the particles in messenger RNA (mRNA).

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the development of its next-generation mRNA-launched enveloped virus-like particle (eVLP) technology, which expands on the company’s current proprietary eVLP technology by coding the particles in messenger RNA (mRNA).
  • In preclinical studies, VBI’s new mRNA-launched eVLP (MLE) technology has demonstrated an ability to generate stronger B- and T-cell signals than those seen with other mRNA vaccines tested.
  • The MLE technology also has the added benefit of streamlined and accelerated chemistry, manufacturing, and control (CMC) processes and manufacturing timelines, similar to other known mRNA vaccine production platforms.
  • “Our MLE technology uses the human body as a bioreactor to produce complex proteins that mimic the natural viral targets, stimulating a strong functional immune response.

HANZA expands annual manufacturing volume for Mitsubishi Logisnext Europe by over 100 MSEK

Retrieved on: 
Thursday, July 13, 2023
Disclosure, SEK, MLE, Arms industry, Mobile phone, EU

STOCKHOLM, July 13, 2023 /PRNewswire/ -- HANZA has today signed a manufacturing agreement with Mitsubishi Logisnext Europe ("MLE"), a leading provider of logistics solutions with self-designed innovative, high-quality forklifts.

Key Points: 
  • STOCKHOLM, July 13, 2023 /PRNewswire/ -- HANZA has today signed a manufacturing agreement with Mitsubishi Logisnext Europe ("MLE"), a leading provider of logistics solutions with self-designed innovative, high-quality forklifts.
  • The agreement expands the existing co-operation between the parties substantiallt and will add an estimated order value exceeding SEK 100 million per year.
  • The parties have agreed on an additional manufacturing solution whereby co-operation is extended to include further sourcing, manufacturing and assembly operations.
  • At full volume, the new order value is expected to exceed 100 MSEK per year.

Greenlight Guru Further Extends Commitment to Quality for Customers with Earning Both ISO 9001 and ISO 27001 Certifications

Retrieved on: 
Thursday, July 21, 2022
ISO, Sound, ISMS, International Organization for Standardization, Quality, Gaps, MLE, CEO, Culture, Software, Risk, Quality management system, Certification, QMS, Information, Medtech, Audit, Management, Risk management

INDIANAPOLIS, July 21, 2022 /PRNewswire-PRWeb/ -- Greenlight Guru, pioneer of the world's first MedTech Lifecycle Excellence Platform, announced today that it is now certified by the International Standards Organization for both ISO 9001 - Quality Management System Requirements and ISO 27001 - Information Security Management System Requirements.

Key Points: 
  • Greenlight Guru has met these requirements and achieved certification for both their own Quality Management System and data security processes, and is able to further meet the needs of their customers.
  • "These ISO certifications are a huge testament to the next step of our ongoing commitment to quality," said Mark Alpert, Director of Quality at Greenlight Guru.
  • "This is a major accomplishment for our team and I am elated to see their hard work recognized in these certifications," added David DeRam, CEO of Greenlight Guru.
  • Hundreds of MedTech companies leverage the Greenlight Guru platform to bring high-quality devices to market globally while optimizing resources and mitigating risk.

Greenlight Guru Unveils the World's First MedTech Lifecycle Excellence Platform to Enable Success Across The Entire Product Lifecycle

Retrieved on: 
Thursday, June 16, 2022
Solution, EDC, ISO, FDA, Digital divide, Intelligence, Technology, Compliance, MLE, Company, PLM, Research, McKinsey & Company, Machine learning, List, QMS, Patient, Medtech, Capas, Organization, Pharma, Risk, Risk management, Medical device

INDIANAPOLIS, June 16, 2022 /PRNewswire-PRWeb/ -- Greenlight Guru, pioneer of industry-dedicated MedTech software solutions, officially announced its MedTech Lifecycle Excellence (MLE) platform to revolutionize how medical device and technology companies bring life-changing products to patients. The platform integrates cross-functional teams, processes, and data throughout the product lifecycle, giving visibility and traceability beyond compliance requirements to proactively overcome execution gaps and accelerate success.

Key Points: 
  • The platform integrates cross-functional teams, processes, and data throughout the product lifecycle, giving visibility and traceability beyond compliance requirements to proactively overcome execution gaps and accelerate success.
  • "MedTech professionals deserve better solutions for the challenging, inspiring, life-changing work they do day-to-day," said Greenlight Guru CEO, David DeRam.
  • Platforms that enable digital threads of product data throughout the entire product lifecycle to drive improved patient outcomes."
  • Greenlight Guru is the only dedicated MedTech Lifecycle Excellence Platform designed specifically for medical technology companies.

ML Environmental Group and Scott Equipment Company Form Strategic Partnership to Expand Waste Recycling Solutions for U.S. Clients

Retrieved on: 
Friday, March 11, 2022
C&D, Partnership, Miracle Recreation Equipment Company, Business development, MLE, Engineering, Recycling, Political movement, Leadership, GLOBE, Turbocharger, Technology, Construction, Demolition, Municipal solid waste, Growth, Airline

DENVER, March 11, 2022 (GLOBE NEWSWIRE) -- ML Environmental Group (MLE), parent company to Komptech Americas and Plexus Recycling Technologies , has announced a strategic partnership and exclusive United States* distribution agreement with Scott Equipment Company, industrial equipment manufacturer of the Turbo Separator and GypStream product lines.

Key Points: 
  • DENVER, March 11, 2022 (GLOBE NEWSWIRE) -- ML Environmental Group (MLE), parent company to Komptech Americas and Plexus Recycling Technologies , has announced a strategic partnership and exclusive United States* distribution agreement with Scott Equipment Company, industrial equipment manufacturer of the Turbo Separator and GypStream product lines.
  • Based in Denver, Colorado, MLE is a division of ML Holdings Company and the parent company of Komptech Americas and Plexus Recycling Technologies.
  • Komptech Americas is a leading North American supplier of equipment and systems for processing solid and organics waste for recycling.
  • In addition, Plexus Recycling Technologies provides A.I.-powered robotic sorting systems and inline material processing equipment for solid waste recycling operations.